Making Advanced HMOs Accessible: From Evolutionary Insight to Scalable, Affordable Production
- Understand how human milk oligosaccharides (HMOs) and the infant microbiome evolved together, and why complex HMOs like the LNFP family and DSLNT play a critical role in early-life development
- Examine the current infant formula landscape to understand why high prices and technological barriers have prevented the widespread use of high-concentration HMOs
- Learn how Primogene utilizes safe and scalable technology to achieve commoditylevel pricing so all infants can have access to broad range of HMOs
- Explore how an enzyme-based manufacturing approach follows a regulatory-proven route, comparable to established GOS production processes
- Discover our proven manufacturing capabilities from gram to metric ton scales and explore partnership opportunities to bring these vital nutrients to the market